Antisense Homology Boxes in C5a Receptor and C5a Anaphylatoxin: A New Method for Identification of Potentially Active Peptides

Journal of Immunology

Volumn 157, Issue 10, 1996, Pages 4591-4601

  Baranyi, Lajos ^a,b   Campbell, William ^a,b   Okada, Hidechika ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^b Choju Medical Institute   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; COMPLEMENT RECEPTOR; LEUKOCYTE ANTIGEN; PEPTIDE;

AMINO ACID SEQUENCE; ARTICLE; CELL CULTURE; CHEMISTRY; HISTIOCYTIC LYMPHOMA; HUMAN; IMMUNOLOGY; MOLECULAR GENETICS; NUCLEIC ACID PROBE; PEPTIDE MAPPING; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; ANTIGENS, CD; ANTISENSE ELEMENTS (GENETICS); COMPLEMENT C5A; HUMANS; LYMPHOMA, LARGE-CELL; MOLECULAR SEQUENCE DATA; PEPTIDE MAPPING; PEPTIDES; RECEPTOR, ANAPHYLATOXIN C5A; RECEPTORS, COMPLEMENT; SEQUENCE HOMOLOGY, AMINO ACID; TUMOR CELLS, CULTURED;

EID: 0030588576     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Blalock, J. E. 1992. Complementarity of peptides specified by 'sense' and 'antisense' strands of DNA. TIBTECH 6:140.
2. Trospha, A., J. S. Kizer, and I. M. Chaiken. 1992. Making sense from antisense: a review of experimental data and developing ideas on sense-antisense peptide recognition. J. Mol. Recognit. 5:43.
3. Chou, P. Y., and G. D. Fasman. 1974. Conformational parameters for amino acids in helical, beta-sheet and random coil regions calculated from proteins. Biochemistry 13:211.
4. Bost, K. L., E. M. Smith, and J. E. Blalock. 1985. Similarity between the corticotrophin (ACTH) receptor and a peptide encoded by an RNA that is complementary to ACTH mRNA. Proc. Natl. Acad. Sci. USA 82:1372.
5. Kaiser, E. T., and F. J. Kézdi. 1983. Secondary structures of proteins and peptides in amphiphilic environments (a review). Proc. Natl. Acad. Sci. USA 80:1137.
6. Markus, G., G. L. Tritsch, and R. Parthasarathy. 1989. A model for hydropathy-based peptide interaction. Arch. Biochem. Biophys. 272:433.
7. Eberle, A. N., and M. Huber. 1991. Antisense peptides: tools for receptor isolation? Lack of antisense MSH and ACTH to interact with their sense peptides and induce receptor-specific antibodies. J. Recept. Res. 11:13.
8. Rassmundsen, U. B., and R. D. Hesh. 1987. Antisense peptides: the parathyroid hormone as an experimental example and a critical theoretical view. Biochem. Biophys. Res. Commun. 149:930.
9. Goldstein, A., and D. L. Brutlag. 1989. Is there a relationship between DNA sequences encoding peptide ligands and their receptors? Proc. Natl. Acad. Sci. USA 86:42.
10. Guillemette, G., G. Boulay, S. Gagnon, R. Bosse, and E. Escher. 1989. The peptide encoded by angiotensin II complementary RNA does not interfere with angiotensin II action. Biochem. J. 261:309.
11. Ghiso, J., E. Saball, J. Leoni, A. Rostagno, and B. Frangione. 1990. Binding of cystatin C to C4: the importance of sense-antisense peptides in their interaction. Proc. Natl. Acad. Sci. USA 87:1288.
12. Bost, K. L., and E. J. Blalock. 1989. Complementary peptides as interactive sites for protein binding. Viral Immunol. 2:229.
13. Draper, K. 1989. Self-complementary regions in human albumin mRNA encode important structural regions within the human albumin protein. Biochem. Biophys. Res. Commun. 163:466.
14. Baranyi, L., W. Campbell, and H. Okada. 1995. The antisense homology box: a new motif within proteins that encodes biologically active peptides. Nature Med. 9:894.
15. Dennis, E. C. 1986. Complement: mediators of inflammation. In Immunobiology of the Complement System. G. D. Ross, ed. Academic Press Inc. Harcourt Brace Jovanovich Publishers, San Diego, CA, p. 63.
16. Gerard, N., and C. Gerard. 1991. The chemotactic receptor for human C5a anaphylatoxin. Nature 349:614.
17. Posnett, D. N., H. McGrath, and J. P. Tam. 1988. A novel method for producing anti-peptide antibodies. J. Biol. Chem. 263:1719.
18. Hamilton, T. A., and D. O. Adams. 1987. Molecular mechanisms of signal transduction in macrophages. Immunol. Today 8:151.
19. Brentani, R. R. 1990. Complementary hydropathy and the evolution of interacting polypeptides. J. Mol. Evol. 31:239.
20. Yomo, T., I. Urabe, and H. Okada. 1992. No stop codons in the antisense strands of the genes for nylon oligomer degradation. Proc. Natl. Acad. Sci. USA 89:3780.
21. Kornblitt, A. R., K. Vibe-Pedersen, and F. E. Baralle. 1984. Human fibronectin: cells specific alternative mRNA splicing generates polypeptide chains differing in the number of internal repeats. Nucleic Acids Res. 12:5853.
22. Tittigger, C., S. Whyard, and V. K. Walker. 1993. A novel intron site in the triosephosphate isomerase gene from mosquito Culex tarsalis. Nature 361:470.
23. Sanz, I. 1991. Multiple mechanisms participate in the generation of diversity of human H chain CDR3 regions. J. Immunol. 147:1720.
24. Fassina, G., R. Consonni, L. Zetta, and G. Cassani. 1992. Design of hydropathically complementary peptides for human big endothelin affinity purification. Int. J. Pept. Protein Res. 39:540.
25. Fassina, G., S. S. Thorgeirson, and J. G. Omichinski. 1989. Sequence-directed design of recognition peptides. In Methods in Protein Sequence Analysis. B. Wittman-Liebold, ed. Springer Verlag, Berlin, p. 431.
26. Bass, B. L., and H. Weintraub. 1987. A developmentally regulated activity that unwinds RNA duplexes. Cell 48:607.
27. Melton, D. A., and M. R. Rebagliatti. 1987. Antisense RNA injection in fertilized frog eggs reveals an RNA duplex unwinding activity. Cell 48:599.
28. Perret, J. J., E. Raspe, G. Vassart, and M. Parmentier. 1992. Cloning and functional expression of canine anaphylatoxin C5a receptor. Biochem. J. 288:911.
29. Li, W. H., C. L. Wu, and C. C. Luo. 1985. A new method of estimating synonymous and nonsynonymous rates of nucleotide substitution considering the relative likelihood of nucleotide and codon changes. Mol. Biol. Evol. 2:150.
30. Zuiderweg, E. R. P., J. Henkin, K. W. Mollison, G. W. Carter, and J. Greer. 1988. Comparison of model and nuclear magnetic resonance structures for the human inflammatory protein C5a. Proteins Struct. Funct. Genet. 3:139.
31. Zuiderweg, E. R., and S. W. Fesik. 1989. Heteronuclear three-dimensional NMR spectroscopy of the inflammatory protein C5a. Biochemistry 28:2387.
32. Zuiderweg, E. R., K. W. Mollison, J. Henkin, and G. W. Carter. 1988. Sequence-specific assignments in the 1H NMR spectrum of the human inflammatory protein C5a. Biochemistry 27:3568.
33. Gerard, C., D. Cheenoweth, and T. E. Hugh. 1980. Human C5a and C5a analogs as probes of the neutrophil C5a receptor. Mol. Immunol. 17:157.
34. Cheenoweth, D. E., B. W. Erickson, and T. E. Hugli. 1979. Human C5a related synthetic peptides as neutrophil chemotactic factors. Biochem. Biophys. Res. Commun. 86:227.
35. Fernandez, H. N., and T. E. Hugli. 1978. Primary structure analysis of the polypeptide portion of human C5a anaphylatoxin. J. Biol. Chem. 253:6955.
36. Ember, J. A., S. D. Sanderson, S. M. Taylor, M. Kawahara, and T. E. Hugh. 1992. Biologic activity of synthetic analogs of C5a anaphylatoxin. J. Immunol. 148:3165.
37. Cheenoweth, D. E., and T. E. Hugli. 1980. Human C5a and C5a analogs as probes of the neutrophil C5a receptor. Mol. Immunol. 17:151.
38. desArg-74. J. Biol. Chem. 260:2613.
39. Oppermann, M., U. Raedt, T. Hebell, B. Schmidt, B. Zimmermann, and O. Götze. 1993. Probing of the human receptor for C5a anaphylatoxin with site-directed antibodies: identification of a potential ligand binding site on the NH2-terminal domain. J. Immunol. 151:3785.
40. Pease, J. E, D. R. Burton, and M. D. Barker. 1994. Site-directed mutagenesis of the complement C5a receptor-examination of the model for its interaction with the ligand C5a. Mol. Immunol. 31:733.
41. Monk, P. N., J. E. Pease, G. Marland, and M. D. Baker. 1994. Mutation of aspartate 82 of the human C5a receptor abolishes the secretory response to human C5a in transfected rat basophilic leukemia cells. Eur. J. Immunol. 24:2922.
42. Konteatis, Z., S. J. Siciliano, G. V. Riper, C. J. Molineaux, S. Pandya, P. Fisher, H. Rosen, R. A. Mumford, and M. S. Springer. 1994. Development of C5a receptor antagonists. J. Immunol. 153:4200.
43. Gerard, C., and P. N. Gerard. 1994. The pro-inflammatory seven-transmembrane receptors of the leukocytes. Curr. Opin. Immunol. 6:140.
44. Milligan, G. 1994. Mechanisms of multifunctional signalling by G-protein linked receptors. Trends Pharmacol Sci. 14:239.
45. Robb, S., T. R. Cheek, F. L. Hannan, L. M. Hall, J. M. Midgley, and P. D. Evans. 1994. Agonist-specific coupling of a cloned drosophila octopamin/tyramin receptor to multiple second messenger systems. EMBO J. 13:1325.
46. Johnson, R. J., and D. E. Cheenoweth. 1985. Labeling of the granulocyte C5a receptor with a unique photoreactive probe. J. Biol. Chem. 260:7161.
47. Grötzinger, J., M. Engels, E. Jacoby, A. Wollmer, and W. Strassburger. 1991. A model for the C5a receptor and for its interaction with the ligand. Protein Eng. 4:767.
48. Shai, Y., T. K. Brunck, and I. M. Chaiken. 1989. Antisense peptide recognition of sense peptides: sequence simplification and evaluation of forces underlying the interaction. Biochemistry 28:8804.
49. Gerard, C., and N. P. Gerard. 1994. C5a anaphylatoxin and its seven transmembrane segment receptor. Annu. Rev. Immunol. 12:775.
50. Rollins, T. E., S. Siciliano, and M. S. Springer. 1988. Solubilization of the functional C5a receptor from human polymorphonuclear leukocytes. J. Biol. Chem. 263:520.